News Search

Tal Korem, PhD, shares how his lab is using a new decontamination method to prevent blood-borne microbial DNA samples from contamination and improve cancer diagnostic tools.

After being diagnosed in 2001 with chronic lymphocytic leukemia and again in 2018 with lung cancer, Mary Ann is now successfully managing her disease and returning to her calling as an actress.

Columbia researchers have shined new light on how the “dark” part of the genome allows cancer cells to be detected by the immune system, which could lead to better immunotherapies.

The award recognizes Dr. Dalla-Favera's over 40-year career working to advance scientific understanding of lymphoma and cancer genetics.